Company
myNEO Therapeutics
Neoantigen and target discovery for the therapies you are building
Also known as myNEO BV
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Ghent, Belgium
- Founded
- 2018
- Customers
- vaccine, T-cell, and biologics teams
- Legal name
- myNEO BV
- myneotx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
myNEO Therapeutics is an AI-driven immunotherapy company. We collaborate with vaccine, T-cell, and biologics teams to find the immune targets their programs need. From there we help with design, analysis, and visualization of what comes next. The aim is safer, more effective immune-based therapies alongside shorter preclinical development timelines.
Products
- Other
- ImmunoEngine
Loading relationship preview